Skip to content

AMWC Japan 2027

AMWC Japan 2027 is planned for November 2027. The organizer has not yet announced the exact dates, city, venue, registration schedule, abstract process, scientific program, speakers, or exhibitor list. The official AMWC Japan background page states that editions from 2027 onward are expected to take place in November.

QuestionCurrent answer
When is AMWC Japan 2027?November 2027; the exact dates have not been announced
Where will it take place?Japan is confirmed by the event identity, but the 2027 city and venue have not been announced
Is registration open?No. The organizer has not opened 2027 registration
Has the program been released?No 2027 program, speaker list, or session timetable was available
Is this the same as AMWC Cannes 2027?No. AMWC Cannes 2027 is a separate congress taking place April 1–3 in Cannes, France

AMWC Japan is the Japan edition of the international Aesthetic & Anti-Aging Medicine World Congress series. It is also separate from AMWC Korea 2027, which is scheduled for June 4–5 in Seoul.

The official organizer page identifies AMWC Japan as a recurring congress that began in 2022. It lists the 2026 edition for September 12–13 at The Prince Park Tower Tokyo and states that editions from 2027 onward are planned for November.

That statement supports the month for AMWC Japan 2027, but it does not confirm that the 2026 Tokyo venue will be reused. Exact dates, city, venue, access format, and planning deadlines should remain pending until the organizer publishes edition-specific information.

AMWC Japan covers aesthetic and anti-aging medicine through scientific sessions, invited speakers, co-sponsored programming, and an industry exhibition. Botulinum toxin can appear within the wider injectables program, but no official source has confirmed a toxin-specific 2027 session, speaker, company, or product participation.

The September 12–13, 2026 congress at The Prince Park Tower Tokyo has open 2026 registration 🔗 and a published 2026 program page 🔗. Its program, speaker list, co-sponsored sessions, and exhibitor directory apply to that edition and do not establish 2027 participation.

When the 2027 program becomes available, toxin-related records should distinguish:

  • independent scientific sessions that explicitly address botulinum toxin
  • live demonstrations or technique sessions involving toxin injection
  • co-sponsored sessions and company workshops
  • exhibitors, sponsors, speakers’ affiliations, and products named in the program

These categories reflect different kinds of scientific and commercial participation and should not be combined into a single evidence class.

ItemCurrent statusWhat to watch for
MonthConfirmed at planning levelNovember 2027
Exact datesPendingEdition-specific start and end dates
City and venuePendingOfficial location and address
RegistrationPendingOpening date, pass types, rates, and eligibility
Abstracts and speakersPendingSubmission rules, deadlines, faculty, and notifications
ProgramPendingDated sessions, rooms, access requirements, and languages
ExhibitionPending2027 floor plan, exhibitors, sponsors, and co-sponsored sessions

Congress programming and exhibition activity can establish topic and company visibility. They do not establish product approval, availability, interchangeability, unit equivalence, comparative efficacy, or clinical superiority.